Clinical trials
Completed Hypercholesterolemia trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 5 |
| Sanofi | 5 |
| Kowa Research Europe | 3 |
| AstraZeneca | 1 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 1 |
| Marjukka Kolehmainen | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Oy Foodfiles Ltd | 1 |
| Raisio Group | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 21 |
| Dyslipidemias | 6 |
| Hyperlipidemias | 2 |
| Anhedonia | 1 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hyperlipoproteinemia Type II | 1 |
| Obesity | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.